Endologix Acquires Pounce Thrombectomy System From Surmodics

Surmodics Acquires Alta Biomed to Expand Medical Device Coating and Testing Capabilities

October 2, 2026

Medical Devices

Surmodics acquired the business of Alta Biomed to expand its portfolio of hemocompatible and biocompatible surface technologies, including the proprietary PzF thin-film surface modification technology. The deal also adds specialized analytical testing capabilities for blood- and tissue-contacting medical devices at Alta Biomed’s Carlsbad, California facility.

Thrombolex Raises $50 Million Series A Financing Led by OrbiMed

March 16, 2026

Medical Devices

Thrombolex, Inc., a commercial-stage medical device company focused on pharmaco-mechanical lysis for thromboembolic diseases, announced the closing of a $50 million Series A equity financing led by OrbiMed. The funding is intended to expand U.S. commercialization and advance clinical evidence generation for its FDA-cleared BASHIR Endovascular Catheter (BEC) platform for pulmonary embolism and other VTE indications.

Verge Medical Acquires RoVo System from 2MG Medical

June 30, 2025

Medical Devices

Verge Medical, a privately held medical technology company based in Campbell, California, acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The asset purchase (with FDA-cleared technology) expands Verge's portfolio of targeted vascular devices to address distal embolization risk during peripheral and coronary interventions.

Haemonetics to Acquire Attune Medical

March 5, 2024

Healthcare Services

Haemonetics Corporation has entered into a definitive agreement to acquire privately held Attune Medical, the manufacturer of the ensoETM proactive esophageal cooling device used during RF cardiac ablation procedures. The deal calls for an upfront cash payment of $160 million at closing, plus additional contingent consideration tied to sales growth and other milestones, and is expected to close in Haemonetics’ fiscal first quarter of 2025.

Stryker Acquires Cerus Endovascular

May 2, 2023

Medical Devices

Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).

Surmodics Acquires Vetex Medical Limited

July 6, 2021

Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) acquired Galway-based Vetex Medical Limited to expand its thrombectomy portfolio with the ReVene Thrombectomy Catheter. The deal included an upfront payment of $39.9 million and up to $7 million in additional milestone payments (with $3.5 million guaranteed), giving Surmodics a second FDA 510(k)-cleared mechanical thrombectomy device and IP to accelerate its thrombectomy platform development.